Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells

Por You, Fanglei, Roberts, Lisa A, Kang, S Peter, Nunes, Raquel A, Dias, Cinara, Iglehart, J Dirk, Solomon, Natalie A, Friedman, Paula N, Harris, Lyndsay N
Publicado em 2008

Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)

Por Nixon, Andrew B., Pang, Herbert, Starr, Mark D., Friedman, Paula N., Bertagnolli, Monica M., Kindler, Hedy L., Goldberg, Richard M., Venook, Alan P., Hurwitz, Herbert I.
Publicado no Clin Cancer Res (2013)

Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581

Por Venook, Alan P., Niedzwiecki, Donna, Lopatin, Margarita, Ye, Xing, Lee, Mark, Friedman, Paula N., Frankel, Wendy, Clark-Langone, Kim, Millward, Carl, Shak, Steven, Goldberg, Richard M., Mahmoud, Najjia N., Warren, Robert S., Schilsky, Richard L., Bertagnolli, Monica M.
Publicado em 2013

Bevacizumab and risk of arterial and venous thromboembolism in metastatic castration-resistant prostate cancer patients treated on Cancer and Leukemia Group B (CALGB) 90401 (Allian...

Por Patel, Jai N., Jiang, Chen, Hertz, Daniel L., Mulkey, Flora A., Owzar, Kouros, Halabi, Susan, Ratain, Mark J., Friedman, Paula N., Small, Eric J., Carducci, Michael A., Mahoney, John F., Kelley, Michael J., Morris, Michael J., Kelly, William K., McLeod, Howard L.
Publicado no Cancer (2014)

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101

Por Baldwin, R. Michael, Owzar, Kouros, Zembutsu, Hitoshi, Chhibber, Aparna, Kubo, Michiaki, Jiang, Chen, Watson, Dorothy, Eclov, Rachel J., Mefford, Joel, McLeod, Howard L., Friedman, Paula N., Hudis, Clifford A., Winer, Eric P., Jorgenson, Eric M., Witte, John S., Shulman, Lawrence N., Nakamura, Yusuke, Ratain, Mark J., Kroetz, Deanna L.
Publicado em 2012

Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)

Por Niedzwiecki, Donna, Frankel, Wendy L., Venook, Alan P., Ye, Xing, Friedman, Paula N., Goldberg, Richard M., Mayer, Robert J., Colacchio, Thomas Anthony, Mulligan, Jude Marie, Davison, Timothy S., O’Brien, Eamonn, Kerr, Peter, Johnston, Patrick G., Kennedy, Richard D., Harkin, D. Paul, Schilsky, Richard L., Bertagnolli, Monica M., Warren, Robert S., Innocenti, Federico
Publicado no J Clin Oncol (2016)

Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy

Por Hertz, Daniel L., Owzar, Kouros, Lessans, Sherrie, Wing, Claudia, Jiang, Chen, Kelly, William Kevin, Patel, Jai, Halabi, Susan, Furukawa, Yoichi, Wheeler, Heather E., Sibley, Alexander B., Lassiter, Cameron, Weisman, Lois, Watson, Dorothy, Krens, Stefanie D., Mulkey, Flora, Renn, Cynthia L., Small, Eric J., Febbo, Phillip G., Shterev, Ivo, Kroetz, Deanna L., Friedman, Paula N., Mahoney, John F., Carducci, Michael A., Kelley, Michael J, Nakamura, Yusuke, Kubo, Michiaki, Dorsey, Susan G., Dolan, M. Eileen, Morris, Michael J., Ratain, Mark J., McLeod, Howard L.
Publicado no Clin Cancer Res (2016)